PT Pyridam Farma Tbk (ISX:PYFA) Cyclically Adjusted Book per Share: Rp (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
61 GF Score
Price Rp246.00
GF Value Rp229.46
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Cyclically Adjusted Book per Share?

PT Pyridam Farma Tbk ISX:PYFA -3.15% 61 Cyclically Adjusted Book per Share is Rp as of Jun. 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 61/100 and a GF Value™ of Rp229.46 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PT Pyridam Farma Tbk's adjusted book value per share for the three months ended in Jun. 2026 was Rp80.030. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is Rp for the trailing ten years ended in Jun. 2026.

During the past 12 months, PT Pyridam Farma Tbk's average Cyclically Adjusted Book Growth Rate was 4.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of PT Pyridam Farma Tbk was 16.20% per year. The lowest was 9.80% per year. And the median was 13.35% per year.

As of today (2026-09-20), PT Pyridam Farma Tbk's current stock price is Rp246.00. PT Pyridam Farma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was Rp. PT Pyridam Farma Tbk's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PT Pyridam Farma Tbk was 7.04. The lowest was 0.69. And the median was 3.15.


PT Pyridam Farma Tbk  (ISX:PYFA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PT Pyridam Farma Tbk was 7.04. The lowest was 0.69. And the median was 3.15.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PT Pyridam Farma Tbk Cyclically Adjusted Book per Share Related Terms


PT Pyridam Farma Tbk Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PT Pyridam Farma Tbk's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Cyclically Adjusted Book per Share Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Pyridam Farma Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ISX:PYFA vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Pyridam Farma Tbk Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's Cyclically Adjusted PB Ratio falls into.


ISX:PYFA
61GF Score
PT Pyridam Farma Tbk ISX:PYFA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Pyridam Farma Tbk Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Pyridam Farma Tbk's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=80.03/137.6954*137.6954
=80.030

Current CPI (Jun. 2026) = 137.6954.

PT Pyridam Farma Tbk Quarterly Data

Book Value per Share CPI Adj_Book
201603 40.997 102.764 54.933
201606 41.678 103.212 55.603
201609 41.756 104.142 55.209
201612 42.336 105.222 55.402
201703 42.862 106.476 55.429
201706 42.207 107.722 53.951
201709 43.770 108.020 55.794
201712 43.679 109.017 55.169
201803 44.336 110.097 55.450
201806 44.364 111.085 54.992
201809 45.405 111.135 56.257
201812 47.720 112.430 58.444
201903 48.477 112.829 59.161
201906 114.730 0.000
202003 51.799 116.252 61.353
202006 52.333 116.630 61.785
202009 56.515 116.397 66.856
202012 63.250 117.318 74.236
202103 66.233 117.840 77.393
202106 70.064 118.184 81.631
202109 73.410 118.262 85.473
202112 67.050 119.516 77.249
202203 68.051 120.948 77.474
202206 70.779 123.322 79.028
202209 182.992 125.298 201.097
202212 177.498 126.098 193.823
202303 172.554 126.953 187.156
202306 162.773 127.663 175.565
202309 159.240 128.151 171.099
202312 143.272 129.395 152.463
202403 125.088 130.607 131.877
202406 120.140 130.792 126.482
202409 106.710 130.361 112.714
202412 92.514 131.432 96.923
202503 86.528 131.948 90.297
202506 76.216 133.241 78.764
202509 65.223 133.819 67.112
202512 87.675 135.271 89.246
202603 83.441 136.539 84.148
202606 80.030 137.695 80.030

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of Rp mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Cyclically Adjusted Book per Share of Rp as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PT Pyridam Farma Tbk and its competitors.
Is PT Pyridam Farma Tbk's Cyclically Adjusted Book per Share too high?
PT Pyridam Farma Tbk's current Cyclically Adjusted Book per Share is Rp. Overall, PT Pyridam Farma Tbk has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Cyclically Adjusted Book per Share of Rp can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PT Pyridam Farma Tbk and its competitors. PT Pyridam Farma Tbk's current Cyclically Adjusted Book per Share is Rp. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp229.46, compared to a current price of Rp246.00 — trading 7.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is Rp. PT Pyridam Farma Tbk's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Cyclically Adjusted Book per Share is Rp as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be overvalued. The current stock price of Rp246.00 is trading 7.2% above its estimated GF Value™ of Rp229.46. GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.

Key valuation signals for ISX:PYFA:

  • Cyclically Adjusted Book per Share: Rp
  • GF Value™: Rp229.46 vs. price of Rp246.00 (7.2% above fair value)
  • GF Score™: 61/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
61GF Score

Get the complete analysis for ISX:PYFA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp246.00
Price
Rp229.46
GF Value